A meta-analysis, including 57 studies conducted on 2838 psoriasis patients, concluded that increased serum levels of IL-2, IL-17, IL-18, and IFN-γ significantly correlated with psoriasis, highlighting their potential role as biomarkers for monitoring disease activity. Here, IL17A is linked to psoriasis.